跳至主要内容
临床试验/JPRN-jRCTb040190118
JPRN-jRCTb040190118已完成未知

Therapeutic angiogenesis by cell transplantation with adipose-derived regenerative cells for critical limb ischemia - TACT-ADRC

Murohara Toyoaki0 个研究点目标入组 29 人开始时间: 2020年2月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
29

研究概览

简要总结

The results of this multicenter clinical trial demonstrate the safety, feasibility, and efficacy of transplanting autologous adipose tissue-derived mesenchymal stem cell progenitor cells for the purpose of antiangiogenic therapy.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 25age old 至 < 80age old(—)
性别
All

入选标准

  • Target disease: PAD, TAO, and Collagen disease-associated vasculitis
  • Patients with
  • (1) 25<= Age <80
  • (2) CLI (Fontaine III-IV), who are not candidates for conventional therapies any more, including surgical revascularization
  • (3) informed consent

排除标准

  • Patients with
  • (1) Insufficient amount of adipose tissue
  • (2) No informed consent
  • (3) Expectation of life < 1 year
  • (4) A past 5 years or current history of malignant disease
  • (5) Untreated coronary heart disease or cerebrovascular diseases
  • (6) Untreated diabetic retinopathy
  • (7) Laboratory signs of chronic or acute inflammation
  • (8) Severe liver or kidney dysfunction
  • (9) Severe anemia or pancytopenia
  • (10) Pregnancy
  • (11) Others

研究者

发起方
Murohara Toyoaki

相似试验

Therapeutic angiogenesis by cell transplantation... | 临床试验